Takeda Pharmaceutical Company Limited

4502.T
Drug Manufacturers - Specialty & Generic
2026/07/24 Updated
Market Cap: $53.7B (¥8.8T)
Stock Price: $33.64 (¥5,505)
Exchange Rate: 1 USD = ¥163.67

Notice on the Completion of Payment for New Share Issuance and Treasury Stock Disposition under the Long-Term Incentive Plan for Our Group Employees Outside Japan

Payment completion for new share issuance and disposition of treasury stock under the overseas group employee Long-Term Incentive Plan. Reflects changes in issued shares and disposed shares; impact on future performance is expected to be minor.

Importance:
Page Updated: July 12, 2026
IR Disclosure Date: July 8, 2026

Key Figures

  • Newly issued shares: 10,892,917 shares
  • Disposal treasury stock: 6,096,159 shares
  • Total shares: 16,989,076 shares
  • Issue price: 5,050 yen/株
  • Total amount: 85,794,833,800 yen
  • Payment date: 2026-07-08

AI要約

Overview of changes

This reports the completion of payment for new share issuance and treasury stock disposition under the Long-Term Incentive Plan for overseas group employees, and the resulting change in issued shares. After the change, the number of newly issued shares is 10,892,917 shares, the number of disposed treasury shares is 6,096,159 shares, the total shares outstanding are 16,989,076, the issue price is ¥5,050 per share, and the total amount is ¥85,794,833,800.

Outlook and impact

The impact of this change on this year’s results is expected to be minor, with the primary purpose limited to payments for employee compensation under the scheme and adjustments for rights and losses. Future IR disclosures may focus on the operation status of the plan and potential dilution effects.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Takeda Pharmaceutical Company Limited

Company overview · Stock price · Financial data · All IR

View company page →